Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 23, 16:00
2169.25
47.95 (2.26%)
VOLUME 25,863
LIVE
NSE
Feb 23, 15:59
2167.05
43.6 (2.05%)
VOLUME 743,506
News on Dr Reddys Laboratories
Select Year: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr Reddy's Chairman, COO added as defendants in US lawsuit

1.30 pm | 19 Feb 2018 |  Source: PTI

Last year in August, the company had said "a law firm representing a purported investor in the company filed a purported class action lawsuit against ...

News highlights of the day: Centre to invest Rs 1.44 lakh crore in road projects in Karnataka

7.07 am | 19 Feb 2018 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Dr Reddy's recalls over 80,000 bottles of Atorvastatin from US

2.55 pm | 08 Feb 2018 |  Source: PTI

Atorvastatin is a drug that blocks the production of cholesterol and reduces its level in the blood....

Dr Reddy's may face delays in launch of gSuboxone as Indivior throws new patent challenge

2.52 pm | 08 Feb 2018 |  Source: Moneycontrol.com

The US unit of Indivior has filed patent lawsuits against generic filers such as Dr Reddy’s, Actavis, Par, Alvogen and Teva for infringement of Unit...

FM's universal healthcare proposal a step in right direction: DRL 

1.48 pm | 08 Feb 2018 |  Source: CNBC-TV18

In an exclusive conversation with CNBC-TV18's Nitya Balakrishnan, Saumen Chakraborty of DRL adds that the company will maintain its capex target o...

Dr Reddy's launches generic Tetrabenazine tablets in US

1.49 pm | 02 Feb 2018 |  Source: PTI

The company's Tetrabenazine tablets have been approved by the United States Food and Drug Administration (USFDA), Dr Reddy's Laboratories said...

Dr Reddy’s Laboratories gains 2% on Tetrabenazine tablets launch in US market

11.52 am | 02 Feb 2018 |  Source: Moneycontrol.com

Tetrabenazine tablets are available in strengths of 12.5 mg and 25 mg, each strength is available in a bottle count size of 112....

Dr Reddy's Laboratories launches Tetrabenazine tablet in US market

11.40 am | 02 Feb 2018 |  Source: Moneycontrol.com

Dr Reddy's Laboratories launched Tetrabenazine tablets, a therapeutic equivalent generic version of Xenazine in the United States market approved ...

News Highlights: Inflation risks overdone; RBI rate cut likely in Aug, says BofAML report

8.49 am | 02 Feb 2018 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Dr Reddy's Labs falls 6% as analysts cut earnings estimates post Q3 nos

6.06 pm | 29 Jan 2018 |  Source: Moneycontrol.com

Nomura said that the Q3 was below estimates, outlook mostly intact. It also said that approval & launches on key products will be key in near term....

Buy Dr Reddy's Laboratories; target of Rs 3450: Dolat Capital

5.37 pm | 29 Jan 2018 |  Source: Moneycontrol.com

Dolat Capital is bullish on Dr Reddy's Laboratories has recommended buy rating on the stock with a target price of Rs 3450 in its research report ...

Hope to resolve Srikakulam with US FDA soon, says DRL 

8.37 am | 29 Jan 2018 |  Source: CNBC-TV18

From the pharmaceutical space, Dr Reddys Laboratories (DRL) reported a mixed set of earnings this quarter. In an interview to CNBC-TV18, Saumen Chakra...

Hope to resolve Srikakulam with US FDA soon, says Dr Reddy's

8.37 am | 29 Jan 2018 |  Source: CNBC-TV18

From the pharmaceutical space, Dr Reddys Laboratories (DRL) reported a mixed set of earnings this quarter. In an interview to CNBC-TV18, Saumen Chakra...

Dr Reddy's expects US FDA re-audit of Duvvada plant in next 3-6 months

12.03 pm | 26 Jan 2018 |  Source: Moneycontrol.com

Dr Reddy’s recovery hinges on the clearance of Duvvada plant in the next re-inspection as a large chunk of lucrative pipeline including generic vers...

Dr Reddy's expects US FDA re-audit of Duvvada plant in next 3-6 months

12.03 pm | 26 Jan 2018 |  Source: Moneycontrol.com

Dr Reddy’s recovery hinges on the clearance of Duvvada plant in the next re-inspection as a large chunk of lucrative pipeline including generic vers...

Stocks 360: Here's why Dr Reddys is in focus 

3.52 pm | 25 Jan 2018 |  Source: CNBC-TV18

Watch CNBC-TV18's Ekta Batra give a 360 degree round up on Dr Reddys....

Dr Reddy's Labs Q3 profit tanks 29% to Rs 334.4 cr but North America biz improves QoQ 

12.15 pm | 25 Jan 2018 |  Source: Moneycontrol.com

Sequential decline in bottomline was just 0.88 percent due to improvement in North America business....

Stocks in the news: SBI, IDBI Bank, Gallant Ispat, Biocon, Canara Bank, Quess Corp, NCC, Bhushan Steel 

7.58 am | 25 Jan 2018 |  Source: CNBC-TV18

SBI | IDBI Bank | Gallant Ispat | Biocon | Canara Bank | Quess Corp | NCC | Bhushan Steel | Indian Hotels | Electrosteel Steels and Cadila ar...

Buy Escorts, Mphasis: Ashwani Gujral 

2.11 pm | 24 Jan 2018 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com recommends buying Escorts and Mphasis....

Dr Reddy's recalls single lot of breast cancer drug from US

2.57 pm | 17 Jan 2018 |  Source: PTI

As per the US health regulator's enforcement report for the week of January 17, a single lot of 1,051 vials of Docetaxel injection USP, 20 mg/mL w...

1 2
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.